Delivery Order HHSN275201300024I-HHSN27500007
Award Date
9/14/15
Potential Completion Date
12/31/25
Potential Value
$12M
Federal Agency
National Institute of Child Health and Human Development
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Torrance, CA, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD) to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, a non-profit research organization. The $1,487,910.57 contract supports the NICHD Contraceptive Clinical Trials Network - Male Studies program, an effort to develop new male contraceptive options through clinical trials. The contract was awarded as a delivery order under a larger $10 million multiple-award...
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center is delivering a 28 Day Study under a $2,099,607.44 potential value task order against the National Institutes of Health National Institute of Child Health and Human Development's Contraceptive Clinical Trials Network indefinite delivery contract. The contract has no set-aside designation. As the prime contractor, Lundquist Institute will conduct this clinical trial through December 31, 2021 to evaluate male contraceptive...
This is a delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD) to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, a non-profit research organization. The contract, with a ceiling value of $2,795,103, is part of the NICHD Contraceptive Clinical Trials Network and supports the Male Contraceptive Trials topic area. The work involves evaluating products that have undergone successful preclinical testing for the...
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, a non-profit biomedical research organization, received a $547,946 cost-no-fee Delivery Order contract from the National Institute of Child Health and Human Development (NICHD) to provide services related to protocol development, protocol review, and informal consultation for the Contraceptive Clinical Trials Networks - Male Studies program. This contract is part of a larger $10 million Indefinite Delivery Vehicle...
This federal contract award is for a cost-plus-fixed-fee delivery order issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Health Decisions, Inc., a for-profit clinical research organization based in Morrisville, North Carolina. The $700,175 contract is for the coordination, monitoring, follow-up, evaluation, and completion of a clinical trial for a Nestorone testosterone gel for male contraception. This contract is part of a larger $18.9...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $1,437,209.40 cost-no-fee delivery order was awarded to New York University (NYU) School of Medicine on July 17, 2013 for a contraceptive clinical trial project. The contract has an ultimate completion date of March 31, 2022 and is not set-aside for any specific business type. As part of the award, NYU...
The Department of Health and Human Services' National Institutes of Health (NIH) awarded a $10,032,585.74 delivery order contract to Health Decisions, Inc., a for-profit clinical research organization, to provide coordination of clinical trials for the Nestorone testosterone gel male contraception product. This delivery order contract is part of the NIH's National Institute of Child Health and Human Development (NICHD) Contraception Clinical Trials Network (CCTN) and does not have a set-aside...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to the Magee-Womens Research Institute and Foundation, a non-profit research organization. The $1,585,279 delivery order contract is for a randomized controlled clinical trial to evaluate the efficacy, safety, and acceptability of the C31G female contraceptive. The contract has no set-aside designation and was...
This is a $72,074.71 cost-no-fee delivery order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The order tasks Essential Access Health, a non-profit organization, to assist in the development of new contraceptive products by providing services related to protocol review, protocol development, and activities associated with the NICHD Contraceptive Clinical Trials Network. This award is...
This federal contract award, valued at $655,019.75, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the University of Cincinnati to conduct clinical evaluation of novel female contraceptive products through a Contraceptive Clinical Trial Network. The award facilitates pilot and efficacy studies,...